Case Sharing | 85% Isolation Yield — Expression CMS Glycopeptide Synthesis

Glycopeptides, as functional fragments of glycoproteins, play a key role in uncovering the mysteries of life and drug development. However, traditional chemical synthesis methods often cause problems like sugar chain loss and peptide racemization due to the use of strong bases for deprotection, which has been a major bottleneck in research. A study published in Carbohydrate Research offers a fresh idea: using esterases to achieve mild deacetylation under neutral conditions, combined with glycosyltransferases in a one-pot method to build complex glycopeptides. Throughout the process, the AIS expression CMS mass spectrometer, with its fast and accurate analytical capabilities, provides crucial data support for identifying reaction intermediates and final products.

Research Background: The 'Basic' Challenge in Glycopeptide Synthesis

Glycopeptides are important tool molecules for studying protein glycosylation functions. Currently, the mainstream method for synthesizing glycopeptides is the Fmoc solid-phase synthesis, which uses acetyl groups to protect the hydroxyls on sugars to ensure stability during the synthesis process. However, after synthesis, the traditional way to remove these acetyl protecting groups is by treating them with strong bases like sodium methoxide or sodium hydroxide.

This brings up some problems:

β-elimination: Basic conditions can cause the sugar chain to fall off from serine or threonine residues.

Peptide racemization: Long exposure to a basic environment can lead to racemization at the peptide's chiral centers, creating hard-to-separate isomeric impurities.

Cumbersome operations: After deacetylation, you need to quickly neutralize, purify, and lyophilize before doing the next step.

Figuring out how to avoid these side reactions and achieve mild, continuous glycopeptide synthesis has been a long-term goal for scientists in this field.

Innovation Strategy: Esterases Take the Stage, Ushering in a New Era of Gentle Deacetylation

Professor Yayoi Yoshimura's team from the National Institute of Advanced Industrial Science and Technology (AIST) in Japan has come up with a brand-new chemical enzyme-based synthesis strategy (Figure 1). The main idea is to use a biological enzyme (esterase) instead of a chemical base to carry out the deacetylation reaction under neutral pH conditions.

Figure 1. (A) Traditional chemical method for deacetylation; (B) Newly developed enzymatic deacetylation and continuous glycosylation

The research team screened three commercial esterases and found that the esterase from Bacillus subtilis (BsE) could efficiently remove all the acetyl groups from the fully acetylated glycosyl amino acid substrate (compound 1) under mild conditions at pH 7.5, converting it into the target product (compound 2), while the esterases from pig liver and Pseudomonas fluorescens didn’t work as well.

Challenges and Breakthroughs: From 'Impure' to 'Efficient' BsE

When the team used this commercial BsE directly for deacetylating the more complex MUC1 glycopeptide (compound 3), something unexpected happened. While the deacetylation product was detected, a series of smaller fragment peaks were also found (Figure 2). Analysis showed that this was due to the mixed proteases in the commercial enzyme preparation causing peptide chain degradation.

Figure 2. Deacetylation reactions of Fmoc-Ser[GalNAc(Ac)3-α]-OH 1 by three commercial esterases, monitored by HPLC. The peaks marked with asterisks in the pig liver esterase reaction mixture are mono-deacetylated products, confirmed by AIS ESI-MS analysis.

Facing this challenge, the researchers didn't give up; instead, they turned to genetic engineering. They used an E. coli expression system and successfully produced recombinant BsE free of peptidase contamination. The results were exciting: after treating glycopeptide 3 with the purified recombinant BsE, the reaction was complete in 2.5 days. HPLC and MS analyses both showed that the target deacetylated glycopeptide 4 was generated efficiently, with no detectable peptide degradation or byproducts.

One-Pot Miracle: From Monosaccharides to Antigens

The restructured BsE not only solved the purity issue but also opened up the possibility for one-pot continuous synthesis. The researchers, without any purification after the deacetylation reaction, sequentially added:

Galactosyltransferase (dC1GalT): attaches galactose to GalNAc, producing compound 5.

Sialyltransferase (ST3Gal1): attaches sialic acid to the galactose, ultimately yielding the target product—the sialylated T antigen (sialyl-T) MUC1 glycopeptide 6.

The whole process is done in the same reactor, with no need to separate intermediates, and starting from compound 3, they achieved an 85% isolated yield of the target glycopeptide.

Tech Support: The Key Role of expression CMS in the Entire Synthesis Process

Throughout the whole research process, quickly and accurately analyzing the products of each reaction step is super important. Whether it's screening esterases, identifying by-products, or checking the progress of each glycosylation reaction, mass spectrometry is indispensable.

It's especially worth mentioning that in the deacetylation reaction detection section, the author used an expression CMS mass spectrometer for electrospray ionization mass spectrometry (ESI-MS) analysis, collecting data in negative ion mode to confirm the mono-deacetylated products in the pig liver esterase reaction mixture.

This technique provides the study with:

Efficiency: Quickly confirm the progress and intermediates of deacetylation reactions, such as rapidly identifying the mono-deacetylated products produced by pig liver esterase reactions.

Accuracy: Precisely measure the molecular weight of each step's products, providing decisive evidence for confirming the structures of key intermediates like compounds 5 and 6, as well as the final products. This data is directly used in the 'Experimental' and 'Results and Discussion' sections of papers.

Convenience: As a compact mass spectrometer, it can easily fit into the workflow of a synthetic lab, providing instant feedback for complex biosynthetic reactions and speeding up the development of methodologies.

Summary and Outlook

This study successfully developed a new strategy that uses recombinant esterases for mild deacetylation, combined with glycosyltransferases for one-pot synthesis of complex glycopeptides. This method is:

Mild conditions: The entire process occurs at neutral pH, completely avoiding base-induced β-elimination and peptide racemization.

Easy to use: It enables a continuous reaction from deacetylation to glycan elongation without the need for intermediate purification steps.

Broad applications: It provides a powerful tool for preparing structurally uniform complex glycopeptides and glycoproteins, with great potential to advance glycobiology, vaccine development, and antibody drug research.

Every step forward in synthetic chemistry relies on precise analytical techniques. The expression CMS mass spectrometer, with its outstanding performance, once again proves to be a trusted 'quality guardian' in complex biomolecule synthesis research. Looking ahead, we hope to collaborate with more researchers to explore even more possibilities in life sciences.

Reference: Yoshimura, Y., et al. Carbohydrate Research, 2020, 108023.

Keywords:

HanKing Liquid Chromatography Column

A full-chain peptide solution to tackle common industry pain points